BioSpace News Archive

Business

Bausch Health Companies Inc. Announces Second-Quarter 2018 Results

Second-Quarter 2018 Financial Results

August 7, 2018
·
84 min read
Business

Rallybio Welcomes Laura Ekas, PhD and Eric Watsky, MD, Further Expanding Rallybio’s Drug Acquisition and Development Capabilities

Dr. Ekas and Dr. Watsky now join Rallybio’s co-founders and other veteran industry executives in advancing Rallybio’s mission to identify and accelerate the development of transformative breakthrough therapies for patients with severe and rare disorders.

August 7, 2018
·
4 min read
Business

Eagle Pharmaceuticals, Inc. Reports Second Quarter 2018 Results

Q2 2018 net income was $0.18 per basic and $0.17 per diluted share and adjusted non-GAAP net income of $0.99 per basic and $0.95 per diluted share

August 7, 2018
·
19 min read
Business

Aerpio Pharmaceuticals to Announce Second Quarter 2018 Financial Results and Host Conference Call on Tuesday, August 14, 2018

Aerpio Pharmaceuticals, Inc. announced that its second quarter 2018 financial results will be released before the market opens on Tuesday, August 14, 2018.

August 7, 2018
·
1 min read
Business

TransEnterix, Inc. Reports Operating and Financial Results for the Second Quarter 2018

Total revenue of $6.4 million, including the sale of four Senhance Systems

August 7, 2018
·
15 min read
Business

Cerveau Technologies Inc. Announces Expanded Research Access to Novel Tau Imaging Agent

This expansion has been driven by the increasing interest in [18F]MK-6240 as a developmental and investigational tool in clinical trials.

August 7, 2018
·
1 min read
Health Canada Approves HEMLIBRA for Hemophilia A Patients with Inhibitors

HEMLIBRA is the first new treatment in almost 20 years for this most severe form of hemophilia1 and the only medicine that is self-injected once weekly

August 7, 2018
·
11 min read
Biotech Bay

Eiger BioPharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference

Eiger BioPharmaceuticals, Inc. announced that David Cory, President and CEO, will present a corporate update at the 2018 Wedbush PacGrow Healthcare Conference on August 15 at 2:30 PM ET.

August 7, 2018
·
1 min read
Policy

Absorption Systems’ ACF Bioservices Certified by European Agency for GMP-compliant Alternative Therapeutic Medicinal Product Stability and Product Release Testing

Absorption Systems® and its ACF Bioservices™ subsidiary announced that they have been certified by the European Medicines and Healthcare products Regulatory Agency (MHRA).

August 7, 2018
·
2 min read
Drug Development

Frequency Therapeutics Initiates Phase 1/2 Single Dose Clinical Trial to Evaluate FX-322, a First-in-Class Drug Candidate for Hearing Restoration

Trial marks the first time a potential progenitor cell activator will be tested in adult patients with stable sensorineural hearing loss

August 7, 2018
·
5 min read